Alan Ashworth

30PUBLICATIONS
340CO-AUTHORS
Molecular targetsMolecular evolutionBiomolecular modelling and designPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 08, 2026
Targeting cancer-specific mutations with RNA-triggered chromatin shredding.

|May 06, 2026
Two decades of PARP inhibitor synthetic lethality in cancer.

|Mar 11, 2026
Comparative sequence analysis of the mouse pseudoautosomal region from three inbred strains reveals it to be the most rapidly evolving 'chromosome'.

Takaoki Kasahara, Kazuyuki Mekada, Kuniya Abe

|Feb 13, 2026
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu

|Jan 09, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens.

Jongbin Kim, Galen J Correy, Brendan W Hall

|Nov 26, 2025
Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells.

Xuxu Gou, Huadong Chen, Morgan E Diolaiti

Pageof 5

Frequent Collaborators

13 joint publications

Morgan E Diolaiti

9 joint publications

James S Fraser

7 joint publications

Galen J Correy

7 joint publications

Patrick O'Leary